CyrusOne Stock Forecast, Price & News

CyrusOne (NASDAQ:CONE) Frequently Asked Questions

Is CyrusOne a buy right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CyrusOne in the last year. There are currently 15 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CyrusOne stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CONE, but not buy additional shares or sell existing shares.
View analyst ratings for CyrusOne or view top-rated stocks.

How has CyrusOne's stock price been impacted by Coronavirus?

CyrusOne's stock was trading at $55.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CONE shares have increased by 59.3% and is now trading at $88.97.
View which stocks have been most impacted by COVID-19.

Are investors shorting CyrusOne?

CyrusOne saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 8,450,000 shares, an increase of 19.9% from the November 30th total of 7,050,000 shares. Based on an average daily trading volume, of 2,660,000 shares, the short-interest ratio is currently 3.2 days.
View CyrusOne's Short Interest.

When is CyrusOne's next earnings date?

CyrusOne is scheduled to release its next quarterly earnings announcement on Wednesday, February 16th 2022.
View our earnings forecast for CyrusOne.

How were CyrusOne's earnings last quarter?

CyrusOne Inc. (NASDAQ:CONE) posted its quarterly earnings data on Tuesday, October, 26th. The real estate investment trust reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.99 by $0.94. The real estate investment trust had revenue of $304.10 million for the quarter, compared to analysts' expectations of $290.09 million. CyrusOne had a net margin of 4.44% and a trailing twelve-month return on equity of 1.71%. The business's quarterly revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.96 EPS.
View CyrusOne's earnings history.

How often does CyrusOne pay dividends? What is the dividend yield for CyrusOne?

CyrusOne announced a quarterly dividend on Wednesday, October 27th. Stockholders of record on Monday, January 3rd will be given a dividend of $0.52 per share on Friday, January 7th. This represents a $2.08 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Friday, December 31st.
View CyrusOne's dividend history.

Is CyrusOne a good dividend stock?

CyrusOne pays an annual dividend of $2.08 per share and currently has a dividend yield of 2.33%. CyrusOne has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of CyrusOne is 507.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CyrusOne will have a dividend payout ratio of 49.29% next year. This indicates that CyrusOne will be able to sustain or increase its dividend.
View CyrusOne's dividend history.

What guidance has CyrusOne issued on next quarter's earnings?

CyrusOne issued an update on its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided EPS guidance of $4.030-$4.080 for the period. The company issued revenue guidance of $1.18 billion-$1.20 billion, compared to the consensus revenue estimate of $1.17 billion.

What price target have analysts set for CONE?

17 analysts have issued 1-year price objectives for CyrusOne's shares. Their forecasts range from $72.00 to $100.00. On average, they expect CyrusOne's stock price to reach $87.06 in the next twelve months. This suggests that the stock has a possible downside of 2.1%.
View analysts' price targets for CyrusOne or view top-rated stocks among Wall Street analysts.

Who are CyrusOne's key executives?

CyrusOne's management team includes the following people:

• David H. Ferdman, President, Chief Executive Officer & Director
• John P Hatem, Chief Operating Officer & Executive Vice President
• Katherine Motlagh, Chief Financial Officer & Executive Vice President
• Bill Williams, Chief Information Officer
• Robert Murray Jackson, Secretary, Executive VP & General Counsel

Who are some of CyrusOne's key competitors?

Some companies that are related to CyrusOne include Digital Realty Trust (DLR), Alexandria Real Estate Equities (ARE), Boston Properties (BXP), CoreSite Realty (COR), Kilroy Realty (KRC), Douglas Emmett (DEI), SL Green Realty (SLG), Highwoods Properties (HIW), Hudson Pacific Properties (HPP), Equity Commonwealth (EQC), Corporate Office Properties Trust (OFC), Brandywine Realty Trust (BDN), Piedmont Office Realty Trust (PDM) and Franklin Street Properties (FSP).
View all of CONE's competitors.

What other stocks do shareholders of CyrusOne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CyrusOne investors own include NVIDIA (NVDA), AT&T (T), Micron Technology (MU), AbbVie (ABBV), Enterprise Products Partners (EPD), salesforce.com (CRM), Alibaba Group (BABA), Prologis (PLD), QUALCOMM (QCOM) and Walt Disney (DIS).

What is CyrusOne's stock symbol?

CyrusOne trades on the NASDAQ under the ticker symbol "CONE."

Who are CyrusOne's major shareholders?

CyrusOne's stock is owned by a variety of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (0.33%), Retirement Systems of Alabama (0.25%), Syquant Capital Sas (0.15%), Capital Investment Advisors LLC (0.06%), Spirit of America Management Corp NY (0.06%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own CyrusOne stock include David H Ferdman, Diane M Morefield, Kevin L Timmons, Michael Klayko and Robert M Jackson.
View institutional ownership trends for CyrusOne.

Which institutional investors are selling CyrusOne stock?

CONE stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Retirement Systems of Alabama, Seelaus Asset Management LLC, Future Financial Wealth Managment LLC, Capital Square LLC, Harbor Investment Advisory LLC, Parallel Advisors LLC, and Cox Capital Mgt LLC.
View insider buying and selling activity for CyrusOne or view top insider-selling stocks.

Which institutional investors are buying CyrusOne stock?

CONE stock was purchased by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Long Run Wealth Advisors LLC, Machina Capital S.A.S., Exchange Traded Concepts LLC, Wealthfront Advisers LLC, Capital Investment Advisors LLC, Cutler Group LP, and Sumitomo Mitsui DS Asset Management Company Ltd.
View insider buying and selling activity for CyrusOne or or view top insider-buying stocks.

How do I buy shares of CyrusOne?

Shares of CONE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CyrusOne's stock price today?

One share of CONE stock can currently be purchased for approximately $88.97.

How much money does CyrusOne make?

CyrusOne has a market capitalization of $11.29 billion and generates $1.03 billion in revenue each year. The real estate investment trust earns $41.40 million in net income (profit) each year or $0.41 on an earnings per share basis.

How many employees does CyrusOne have?

CyrusOne employs 441 workers across the globe.

What is CyrusOne's official website?

The official website for CyrusOne is www.cyrusone.com.

Where are CyrusOne's headquarters?

CyrusOne is headquartered at 2850 N. Harwood Street Suite 2200, DALLAS TX, 75201.

How can I contact CyrusOne?

CyrusOne's mailing address is 2850 N. Harwood Street Suite 2200, DALLAS TX, 75201. The real estate investment trust can be reached via phone at (972) 350-0060 or via email at [email protected].